HEMP-IT ADN

INNOVATION

Hemp It Logo Hemp It Adn
A CENTRE OF EXPERTISE WORKING FOR PLANT INNOVATION

A UNIT DEDICATED TO INNOVATION IN INDUSTRIAL HEMP

A source of diversity and value creation, R&D is a strategic priority that is central to the cooperative’s development plans. This is why HEMP-it invests over 15% of its revenue in hemp variety innovation. This investment has led to the creation of a new scientific unit: HEMP-it ADN.

Launched in 2019, HEMP-it ADN is a business unit dedicated to varietal innovation and creation on behalf of the HEMP-it cooperative and the French National Federation of Hemp Producers (FNPC). Led by a dynamic and experienced team, the unit aims to create new varieties for tomorrow’s markets.

Objectives

SELECTING OUR PLANTS

To create varieties that meet new quality criteria and the expectations of producers, manufacturers and consumers.

ACCELERATING THE VARIETAL CREATION PROCESS

By using innovative plant biotechnology.

GUARANTEEING THE QUALITY OF FRENCH INDUSTRIAL HEMP

By promoting the production of high-quality, high-performance seeds.

EXPANDING OUR KNOWLEDGE OF THE PLANT

Through partnerships with research centres and competitive clusters.

R&D

R&D

LA R&D : A RESPONSE TO THE NEEDS OF PRODUCERS, MANUFACTURERS AND CONSUMERS

Varietal innovation is a long and complex process that involves creating new hemp varieties from genetic resources selected for their complementary characteristics, and then selecting the best performers based on agronomic, technological and environmental criteria.

Responding to the needs expressed by producers, manufacturers and consumers, HEMP-it ADN’s engineers and technicians aim to increase genetic resources by creating new varieties of industrial hemp that are better suited to the needs of current and future markets.

Varietal innovation and creation in figures

• 15% of revenue invested in R&D
• €2 million of investment in research (including a €1 million repayable advance from BPI France)
• 1 new biotechnology laboratory for varietal selection
• 8 employees, 3 sites, 2 operational departments
• 2.5 hectares of plots for varietal innovation trials
• 1 French trial network consisting of 4 sites covering 3 hectares
• 1 European and global evaluation network consisting of 4 sites of 3 hectares (Canada, Australia, 2 in New Zealand)

Main research avenues at HEMP-it ADN:

• Adapting to changes in production techniques and industrial processes, aiming to improve consistency and quality
• Better yields
• Technical protocols specific to each production method
• Adapting to regulatory constraints
• Better resistance to pests